Did you miss "Mad Money" on CNBC? If so, here are some of Jim Cramer's top takeaways.
In an "Executive Decision" segment, Cramer also sat down with Joe Capper, president and CEO of BioTelemetry (BEAT) , the medical device maker Cramer featured on Sept. 25.
Capper said that the connected health market is relatively new and no one really knows just how big it could become. In the cardiac monitoring market, however, they estimate the market to be up to $2 billion.
BioTelemetry's cardiac monitor is connected to a patient's smartphone and can be worn for up to 30 days. Events are automatically transmitted to the patient's phone, then onto the cloud where technicians can read them 24/7. This new connected technology takes monitoring to a whole new level, Capper said, and the accuracy is greatly superior to older units.
As for consumer-grade heart monitors like the Apple (AAPL) Watch, Capper said these devices are a great addition to the market, as they can get patients to doctors sooner, where they will transition to FDA-approved devices like theirs for more in-depth monitoring.
Cramer and the AAP team have a preview for PepsiCo's (PEP) earnings. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
A special invitation: Join Cramer, CNBC's Jon Najarian and other experts Oct. 28 in New York.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.